Tomer Kariv's Net Worth

$0

Estimate Recalculated Jun 11, 2025 11:46AM EST

Who is Tomer Kariv

Tomer Kariv does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Keros Therapeutics, Inc., VBI Vaccines Inc/BC, LogicBio Therapeutics, Inc., 89bio, Inc., Eloxx Pharmaceuticals, Inc., and Arno Therapeutics, Inc.

SEC CIK

Tomer Kariv's CIK is 0001568077

Past Insider Trading and Trends

2018 was Tomer Kariv's most active year for acquiring shares with 3 total transactions. Tomer Kariv's most active month to acquire stocks was the month of May. 2019 saw Tomer Kariv paying a total of $0.00 for 230,869 shares, this is the most they've acquired in one year.

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Keros Therapeutics, Inc.

Investor
Updated Jun 11, 2025
Form 4/A
Jun 11, 2025
155.26K
Form 4
10.00K
Jun 03, 2024
10.00K
Grant
May 30
Form 4
10.00K
Jun 08, 2023
10.00K
Grant
Jun 06
Form 4
-0.31%
-14.35K
-$0.71
Nov 30, 2022
4.63M
Options
Nov 29
Form 3/A
Nov 30, 2022
Form 4
8.29K
Jun 03, 2022
8.29K
Grant
Jun 01
Form 4
8.29K
Jun 03, 2021
8.29K
Grant
Jun 01
Form 4
1.27%
60.00K
$50.00
$3.00M
Nov 19, 2020
4.79M
Purchase
Nov 17
Form 4
2.73%
437.50K
$16.00
$7.00M
Apr 13, 2020
16.48M
Purchase
Apr 13
Form 3
Apr 07, 2020
751.91K
Showing 10 results

VBI Vaccines Inc/BC

Investor
Updated Feb 04, 2019
Form 4
200.00K
Feb 04, 2019
200.00K
Grant
Jan 31
Form 4
62.24%
1.43M
$1.40
$2.00M
Dec 18, 2018
3.72M
Purchase
Dec 17
Form 4
75.00K
Jan 29, 2018
75.00K
Grant
Jan 23
Form 3
Jan 29, 2018
2.30M
Showing 4 results

LogicBio Therapeutics, Inc.

Investor
Updated Dec 20, 2019
Form 4
10.87K
Dec 20, 2019
10.87K
Grant
Dec 19
Form 4
-22.69%
-824.25K
$10.00
Oct 25, 2018
2.81M
Buy-Options
Oct 23
Form 4
24.10K
Oct 22, 2018
24.10K
Grant
Oct 18
Form 3
Oct 18, 2018
Showing 4 results

89bio, Inc.

Investor
Updated Nov 13, 2019
Form 4
-79.37%
-4.37M
$16.00
Nov 13, 2019
1.13M
Buy-Options
Nov 11 - Nov 13
Form 3
Nov 08, 2019
Showing 2 results

Eloxx Pharmaceuticals, Inc.

Investor
Updated Jan 31, 2023
Form 4
2.86K
Jan 31, 2023
2.86K
Grant
Jan 30
Form 4
20.00K
Jun 17, 2022
20.00K
Grant
Jun 15
Form 4
20.00K
May 20, 2021
20.00K
Grant
May 19
Form 4
275.43%
5.93M
$1.35
$8.00M
May 17, 2021
15.27M
Purchase
May 13
Form 4
20.00K
May 22, 2020
20.00K
Grant
May 20
Form 4
10.25%
200.00K
$9.00
$1.80M
Jun 26, 2019
9.34M
Purchase
Jun 24
Form 4
20.00K
May 29, 2019
20.00K
Grant
May 29
Form 4
40.00K
Jun 19, 2018
40.00K
Grant
Jun 15
Form 4
21.85%
350.00K
$9.75
$3.41M
May 01, 2018
9.14M
Purchase
Apr 30
Form 4
0.40%
12.60K
$7.78
$97.83K
Mar 23, 2018
10.39M
Purchase
Mar 21 - Mar 22
Form 3
Dec 29, 2017
8.78M
Showing 11 results

Arno Therapeutics, Inc

Investor
Updated Sep 08, 2016
Form 3/A
Sep 08, 2016
382.86K
Form 4
38.87%
1.07M
Aug 17, 2016
3.83M
Purchase
Aug 15
Form 4/A
88.63K
Apr 15, 2016
4.96M
Grant
Apr 07
Form 4
110.70%
1.45M
$0.35
$506.82K
Apr 11, 2016
4.87M
Purchase
Jan 12
Form 4
110.70%
1.45M
$0.35
$506.82K
Jan 14, 2016
4.87M
Purchase
Jan 12
Form 4
34.22K
Jan 28, 2014
3.52M
Grant
Jan 24
Form 4
68.45K
Nov 06, 2013
3.48M
Grant
Nov 04
Form 4
105.12%
1.31M
$2.40
Oct 31, 2013
3.41M
Purchase
Oct 29
Form 4
2.06%
66.67K
$0.30
$20.00K
Jun 05, 2013
14.60M
Acquisition
May 28
Form 4
3.64%
113.97K
$0.30
$34.19K
May 07, 2013
14.53M
Acquisition
Apr 29
Form 4
2.18%
66.67K
$0.30
$20.00K
Apr 10, 2013
14.66M
Acquisition
Mar 27
Form 3
Jan 29, 2013
3.06M
Showing 12 results